Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philipp Schwabl

Showing results (41-50 of 147) with videos related to

Pageof 15
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver|June 24, 2014
New reliability criteria for transient elastography increase the number of accurate measurements for screening of cirrhosis and portal hypertensionPhilipp Schwabl, Simona Bota, Petra Salzl, et al.
The Journal of Infectious Diseases|September 13, 2014
Response-guided boceprevir-based triple therapy in HIV/HCV-coinfected patients: the HIVCOBOC-RGT studyMattias Mandorfer, Sebastian Steiner, Philipp Schwabl, et al.
United European Gastroenterology Journal|May 9, 2019
High efficacy of interferon-free therapy for acute hepatitis C in HIV-positive patientsDavid Chromy, Mattias Mandorfer, Theresa Bucsics, et al.
Microbial Genomics|June 24, 2022
Genome plasticity driven by aneuploidy and loss of heterozygosity in <i>Trypanosoma cruzi</i>Lissa Cruz-Saavedra, Philipp Schwabl, Gustavo A Vallejo, et al.
Microbial Genomics|July 20, 2022
Corrigendum: Genome plasticity driven by aneuploidy and loss of heterozygosity in <i>Trypanosoma cruzi</i>Lissa Cruz-Saavedra, Philipp Schwabl, Gustavo A Vallejo, et al.
Thrombosis and Haemostasis|July 30, 2023
Platelet Function Decreases with Increasing Severity of Liver Cirrhosis and Portal Hypertension-A Prospective StudyKsenia Brusilovskaya, Benedikt Silvester Hofer, Benedikt Simbrunner, et al.
International Journal of Environmental Research and Public Health|December 2, 2020
Assessment of Human Health Risks Posed by Nano-and Microplastics Is Currently Not FeasibleAndreas Brachner, Despina Fragouli, Iola F Duarte, et al.
Journal of Hepatology|September 6, 2016
Metabolic preconditioning protects BSEP/ABCB11<sup>-/-</sup> mice against cholestatic liver injuryClaudia D Fuchs, Gustav Paumgartner, Annika Wahlström, et al.
Hepatology (Baltimore, Md.)|December 27, 2023
Decreased platelet activation predicts hepatic decompensation and mortality in patients with cirrhosisBenedikt S Hofer, Ksenia Brusilovskaya, Benedikt Simbrunner, et al.
Hepatology International|February 9, 2024
FXR-FGF19 signaling in the gut-liver axis is dysregulated in patients with cirrhosis and correlates with impaired intestinal defenceBenedikt Simbrunner, Benedikt S Hofer, Philipp Schwabl, et al.
Pageof 15

Showing results (41-50 of 147) with videos related to

Sort By:
Pageof 15
Liver International : Official Journal of the International Association for the Study of the Liver|June 24, 2014
New reliability criteria for transient elastography increase the number of accurate measurements for screening of cirrhosis and portal hypertensionPhilipp Schwabl, Simona Bota, Petra Salzl, et al.
The Journal of Infectious Diseases|September 13, 2014
Response-guided boceprevir-based triple therapy in HIV/HCV-coinfected patients: the HIVCOBOC-RGT studyMattias Mandorfer, Sebastian Steiner, Philipp Schwabl, et al.
United European Gastroenterology Journal|May 9, 2019
High efficacy of interferon-free therapy for acute hepatitis C in HIV-positive patientsDavid Chromy, Mattias Mandorfer, Theresa Bucsics, et al.
Microbial Genomics|June 24, 2022
Genome plasticity driven by aneuploidy and loss of heterozygosity in <i>Trypanosoma cruzi</i>Lissa Cruz-Saavedra, Philipp Schwabl, Gustavo A Vallejo, et al.
Microbial Genomics|July 20, 2022
Corrigendum: Genome plasticity driven by aneuploidy and loss of heterozygosity in <i>Trypanosoma cruzi</i>Lissa Cruz-Saavedra, Philipp Schwabl, Gustavo A Vallejo, et al.
Thrombosis and Haemostasis|July 30, 2023
Platelet Function Decreases with Increasing Severity of Liver Cirrhosis and Portal Hypertension-A Prospective StudyKsenia Brusilovskaya, Benedikt Silvester Hofer, Benedikt Simbrunner, et al.
International Journal of Environmental Research and Public Health|December 2, 2020
Assessment of Human Health Risks Posed by Nano-and Microplastics Is Currently Not FeasibleAndreas Brachner, Despina Fragouli, Iola F Duarte, et al.
Journal of Hepatology|September 6, 2016
Metabolic preconditioning protects BSEP/ABCB11<sup>-/-</sup> mice against cholestatic liver injuryClaudia D Fuchs, Gustav Paumgartner, Annika Wahlström, et al.
Hepatology (Baltimore, Md.)|December 27, 2023
Decreased platelet activation predicts hepatic decompensation and mortality in patients with cirrhosisBenedikt S Hofer, Ksenia Brusilovskaya, Benedikt Simbrunner, et al.
Hepatology International|February 9, 2024
FXR-FGF19 signaling in the gut-liver axis is dysregulated in patients with cirrhosis and correlates with impaired intestinal defenceBenedikt Simbrunner, Benedikt S Hofer, Philipp Schwabl, et al.
Pageof 15